host disease
Cynata Completes Patient Enrolment in Phase 2 aGvHD Clinical Trial
Cynata Therapeutics; CYP-001; Phase 2 trial; acute graft versus host disease; aGvHD; patient enrolment
Actionable Insights Powered by AI
Cynata Therapeutics; CYP-001; Phase 2 trial; acute graft versus host disease; aGvHD; patient enrolment